Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BUDD-CHIARI SYNDROME, SUSCEPTIBILITY TO, SOMATIC
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 0 | ||||||||
Splenomegaly
|
19 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 0 | ||||||||
Erythrocytosis familial, 1
|
14 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.710 | 1.000 | 1 | 2008 | 2008 | |||||
High density lipoprotein measurement
|
1440 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||
5q-syndrome
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Acquired von Willebrand's disease
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Acromegaly
|
25 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Activated Protein C Resistance
|
30 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Acute Chest Syndrome
|
135 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Acute erythroleukemia
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Acute lymphocytic leukemia
|
222 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Adjustment Disorders
|
4 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Adult Lymphoma
|
66 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
anemia hemoglobin
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Arteriopathic disease
|
14 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Autoimmune thrombocytopenia
|
7 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
B-CELL MALIGNANCY, LOW-GRADE
|
19 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Behcet Syndrome
|
243 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1 | 2012 | 2012 | ||||||
Blast Phase
|
14 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1 | 2006 | 2006 | ||||||
Blood Coagulation Disorders
|
31 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Breast Carcinoma
|
2793 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Cerebrovascular accident
|
591 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Childhood Lymphoma
|
66 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2005 | 2005 |